Latest Articles

Publication Date
Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis.

Endometriosis, a chronic inflammatory condition characterized by pain and infertility, remains a clinical challenge. Current hormonal and surgical treatments are often limited by side effects and high recurrence rates. In …

Published: Feb. 7, 2026, midnight
Proteomics International pivots to sales with management shake-up - The Age

Proteomics International pivots to sales with management shake-up The Age

Published: Jan. 14, 2026, 4:13 a.m.
Proteomics International pivots to sales with management shake-up - Brisbane Times

Proteomics International pivots to sales with management shake-up Brisbane Times

Published: Jan. 14, 2026, 4:13 a.m.
Endometrial Stromal Cells from Endometriosis Patients Reflect Lesion-Type-Specific Heterogeneity.

Endometriosis, a disease affecting about one out of ten women, is characterized by the growth of endometrial-like tissue outside the uterine cavity. There is significant disease heterogeneity, but the pathophysiological …

Published: Nov. 28, 2025, midnight
Proteomics International Secures Grant for Endometriosis Diagnostic Test - MSN

Proteomics International Secures Grant for Endometriosis Diagnostic Test MSN

Published: Nov. 25, 2025, 2:30 p.m.
Proteomics $2.2M R&D rebate to fuel diagnostics test rollout - The Sydney Morning Herald

Proteomics $2.2M R&D rebate to fuel diagnostics test rollout The Sydney Morning Herald

Published: Nov. 12, 2025, 5:39 a.m.
Proteomics International secures WA Government grant to advance world-first blood test for endometriosis - BiotechDispatch

Proteomics International secures WA Government grant to advance world-first blood test for endometriosis BiotechDispatch

Published: Nov. 9, 2025, midnight
Proteomics International Secures Grant for Endometriosis Diagnostic Test - TipRanks

Proteomics International Secures Grant for Endometriosis Diagnostic Test TipRanks

Published: Nov. 6, 2025, 8:43 a.m.
Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test - MarketScreener

Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test MarketScreener

Published: Nov. 6, 2025, 6:30 a.m.
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Test for Endometriosis Receives $0.5m Grant - ABN Newswire

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Test for Endometriosis Receives $0.5m Grant ABN Newswire

Published: Nov. 6, 2025, 3:51 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!